Conditions: Ovarian Cancer
Keywords: Advanced, refractory, or recurrent ovarian cancer
Enrollment: 129
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if the study drug pertuzumab is effective in treating patients with advanced ovarian cancer that is refractory to, or has recurred following, prior chemotherapy.

Detailed description:

Arms:

Interventions: intervention 1: Pertuzumab (rhuMAb 2C4)
Intervention descriptions: intervention 1: None

Protocol document: